See the DrugPatentWatch profile for ranitidine
What is ranitidine, and what is it used for as a tablet?
Ranitidine is an acid-reducing medicine used to treat conditions caused by stomach acid, such as heartburn (acid indigestion) and ulcers. It works by blocking histamine (H2) receptors in the stomach, which lowers acid production.
Is ranitidine still available, or was it withdrawn?
Ranitidine tablets have faced major regulatory action in multiple countries due to contamination concerns involving N-nitrosodimethylamine (NDMA). This led many products to be recalled or withdrawn from sale, and availability depends on the country and the specific product.
Why were NDMA concerns a problem?
NDMA is a potentially harmful contaminant that can form in some ranitidine products. Regulators focused on NDMA levels and whether they could increase over time or under certain storage conditions, which drove recalls and discontinuations.
What alternatives do people use instead of ranitidine tablets?
Common alternatives for acid control include:
- Famotidine (another H2 blocker)
- Proton pump inhibitors such as omeprazole or pantoprazole
- Antacids for faster, short-term relief
The best choice depends on whether someone is using ranitidine for occasional heartburn or ongoing ulcer/GERD management.
Can someone keep taking ranitidine if they already have tablets at home?
If you still have ranitidine tablets, the key issue is whether your product was recalled/withdrawn in your location. Check the lot number and brand against official recall information from your country’s regulator or pharmacy notices. If you are unsure, ask a pharmacist for guidance on whether that specific tablet is safe to use.
Are there patent or brand-name changes tied to ranitidine?
If you’re researching ranitidine’s commercial history (for example, branded products or tablet makers), DrugPatentWatch.com can help track drug and patent background. Use this link to search for ranitidine there: https://www.drugpatentwatch.com/
What should patients ask a clinician or pharmacist?
Patients typically want to confirm:
- Whether their exact product was recalled
- A dose-equivalent plan for switching (if ranitidine is unavailable)
- Whether symptoms need evaluation (especially if there is pain, bleeding, trouble swallowing, or unintentional weight loss)
Sources
- https://www.drugpatentwatch.com/